论文信息 - Correspondence on “Prospective phenotyping of long-term survivors of generalized arterial calcification of infancy (GACI)” by Ferreira et al. - 字舞流文

Correspondence on “Prospective phenotyping of long-term survivors of generalized arterial calcification of infancy (GACI)” by Ferreira et al.

I. Salusky | B. Gales | F. Rutsch | D. Levi | R. Stern

[1] Ellen F. Macnamara,et al. Prospective phenotyping of long-term survivors of Generalized Arterial Calcification of Infancy (GACI) , 2020, Genetics in Medicine.

[2] C. Ferreira,et al. Generalized Arterial Calcification of Infancy: New Insights, Controversies, and Approach to Management , 2020, Current Osteoporosis Reports.

[3] F. Glorieux,et al. Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial , 2019, The Lancet.

[4] J. S. San Martin,et al. Burosumab Therapy in Children with X‐Linked Hypophosphatemia , 2018, The New England journal of medicine.

[5] W. Gahl,et al. Treatment of hypophosphatemic rickets in generalized arterial calcification of infancy (GACI) without worsening of vascular calcification , 2016, American journal of medical genetics. Part A.

[6] R. Terkeltaub,et al. Hypophosphatemia, Hyperphosphaturia, and Bisphosphonate Treatment Are Associated With Survival Beyond Infancy in Generalized Arterial Calcification of Infancy , 2008, Circulation. Cardiovascular genetics.

[7] C. Kleinman,et al. Ectopic cardiac calcification associated with hyperparathyroidism in a boy with hypophosphatemic rickets. , 2001, Current opinion in pediatrics.